Related Experiment Video
Updated: Oct 3, 2026

Characterization of Cell Membrane Extensions and Studying Their Roles in Cancer Cell Adhesion Dynamics
Published on: March 26, 2018
Cancer and diabetes: two pathological conditions in which adrenomedullin may be involved
R Pío1, A Martínez, F Cuttitta
1Department of Biochemistry, School of Medicine, University of Navarra, 31080, Pamplona, Spain.
Abstract:
Adrenomedullin (AM) is a regulatory peptide involved in several physiological processes. Among them, AM has been implicated in the regulation of growth, both with mitogenic and antiproliferative activities on normal cells. AM is widely expressed during embryogenesis and may have a significant role in the proliferation and differentiation processes associated with development. AM is also expressed by cancer cell lines and tumors and has been implicated in the growth of malignant cells. Some additional activities associated with AM (antiapoptotic capabilities, angiogenic potential, and upregulation in hypoxic conditions), together with its wide distribution in cancer, suggest that AM may be an important factor in carcinogenesis. Besides its implication in growth, embryogenesis and tumor biology, AM is also involved in pancreatic regulation and diabetes. AM regulates insulin secretion and is overexpressed in the plasma of diabetic patients. Several findings indicate that AM may participate in the pathogenesis and/or clinical complications of this disease.
Insights
Adrenomedullin (AM) peptide influences cell growth and development, playing roles in both normal embryogenesis and cancer progression. AM also impacts pancreatic function and diabetes, affecting insulin secretion and disease pathogenesis.
Area of Science:
- Endocrinology
- Molecular Biology
- Oncology
Background:
- Adrenomedullin (AM) is a peptide hormone with diverse physiological roles.
- AM exhibits both mitogenic and antiproliferative effects on normal cells.
- Its expression is significant during embryogenesis and in various cancer cell lines.
Purpose of the Study:
- To investigate the multifaceted roles of Adrenomedullin (AM) in biological processes.
- To explore AM's involvement in cell growth, embryogenesis, and tumor biology.
- To examine the connection between AM, pancreatic regulation, and diabetes mellitus.
Main Methods:
- Literature review of studies on Adrenomedullin (AM) functions.
- Analysis of AM's expression patterns in normal and cancerous tissues.
- Examination of AM's impact on insulin secretion and diabetic patient data.
Main Results:
- AM influences normal cell proliferation and differentiation during development.
- AM expression in tumors suggests a role in carcinogenesis, with properties like anti-apoptosis and angiogenesis.
- AM dysregulation is observed in diabetes, affecting insulin secretion and potentially contributing to disease pathology.
Conclusions:
- Adrenomedullin (AM) is a key regulator in embryogenesis, cancer, and metabolic disorders like diabetes.
- Further research into AM's mechanisms can offer insights into therapeutic strategies for these conditions.
Related Concept Videos
Adrenal Gland Disorders
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Psychoneuroimmunology: Diabetes and Cancer
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type II Diabetes II: Pathophysiology
Diabetes Mellitus: Introduction
Type I Diabetes II: Pathophysiology